Menu
SOPHiA GENETICS™ is excited to be a part of the European Society of Human Genetics annual meeting, held in person in Glasgow, Scotland, UK from June 10th-13th.
You will have the chance to chat with our experts at booth #606 and demo the universal SOPHiA DDM™ Platform.
We are also happy to invite you to our symposium taking place on Sunday, June 11, from 08.30am to 10.00am BST at level 0 in room Alsh 2. See here below for the details:
Progress in the Adoption of Exome and Pharmacogenetics Analysis
At SOPHiA GENETICS, we collaborate with genetic experts to develop specialized next-generation sequencing (NGS) applications that seamlessly integrate into any laboratory workflow. Today, our partners share how the analytical technology and dedicated features in the SOPHiA DDM™️ Platform have enabled the accurate detection and streamlined assessment of variants associated with Rare Diseases and Pharmacogenomics.
Join us to discover how the SOPHiA DDM™️ Platform:
You cannot join us onsite in Glasgow? Not a problem, ESHG is a hybrid event. Register to the event for online participation and watch our talk live: https://ter.li/yqsjfh
SOPHiA GENETICS products are for Research Use Only and not for use in diagnostic procedures unless specified otherwise.
SOPHiA DDM™ Dx Hereditary Cancer Solution, SOPHiA DDM™ Dx RNAtarget Oncology Solution and SOPHiA DDM™ Dx Homologous Recombination Deficiency Solution are available as CE-IVD products for In Vitro Diagnostic Use in the European Economic Area (EEA), the United Kingdom and Switzerland. SOPHiA DDM™ Dx Myeloid Solution and SOPHiA DDM™ Dx Solid Tumor Solution are available as CE-IVD products for In Vitro Diagnostic Use in the EEA, the United Kingdom, Switzerland, and Israel. Information about products that may or may not be available in different countries and if applicable, may or may not have received approval or market clearance by a governmental regulatory body for different indications for use. Please contact us at [email protected] to obtain the appropriate product information for your country of residence.
All third-party trademarks listed by SOPHiA GENETICS remain the property of their respective owners. Unless specifically identified as such, SOPHiA GENETICS’ use of third-party trademarks does not indicate any relationship, sponsorship, or endorsement between SOPHiA GENETICS and the owners of these trademarks. Any references by SOPHiA GENETICS to third-party trademarks is to identify the corresponding third-party goods and/or services and shall be considered nominative fair use under the trademark law.
